Share Prices & Company Research

Market News

25 Jun 2019 | 13:28

C4X Discovery forms collaboration pact with PhoreMost

Drug discovery company C4X Discovery Holdings said it had entered into a collaboration with PhoreMost.

The collaboration, initially focused on Parkinson's disease, would combine both company's technology platforms.

'As part of our strategy to become the world's most productive drug discovery company, we continually assess cutting edge technologies that add to our current capabilities in target identification and drug design,' chief executive Clive Dix said.

'PhoreMost has one such technology with the potential to both validate targets and provide chemistry starting points for our molecular design platforms.'

'This partnership complements C4XD's existing target validation collaborations and enables us to accelerate our portfolio growth whilst decreasing the timelines in drug discovery.'

At 1:28pm: (LON:C4XD) C4x Discovery Holdings Plc share price was +0.5p at 51p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.